A new vantage point on inflammation and fibrosis
Mirador Therapeutics is a clinical-stage precision medicine company developing targeted therapies for immune-mediated inflammatory and fibrotic diseases. Using Mirador360™, an integrated platform with multi-modal data, AI, and advanced analytics, it identifies novel targets and optimal therapies to accelerate pipeline development.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountOct 2025
Mar 2024
Create a free account to see which investors have funded this company.
Create Free Account
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
